Skip to main content
. 2015 Apr 2;3:14. doi: 10.1186/s40337-015-0050-6

Table 1.

Demographic and clinical characteristics of anorexia nervosa patients (AN), bulimia nervosa patients (BN), and healthy controls (HC)

Eating disorders Healthy control
AN (n = 22) BN (n = 36) HC (n = 51)
Observed mean, M(SD) Mean SD Mean SD Mean SD F-value p-value Post hoc
Age (years) 25.77 6.26 25.94 5.81 23.82 5.58 1.71 0.19 n.s.
Education (years) 13.23 2.20 14.07 1.87 14.00 0.91 1.24 0.30 n.s.
Duration of illness (only AN, BN) 7.24 6.47 7.15 5.80 0.00 0.96 n.s.
BMI (kg/m2) 15.87 2.62 19.76 2.38 20.99 1.71 76.83 0.00 HC>AN, HC>BN, BN>AN
TAS-20 60.07 7.95 64.00 8.16 49.50 9.71 26.89 0.00 AN>HC, BN>HC
HADSa 11.06 4.29 12.00 3.87 4.61 3.39 42.55 0.00 AN>HC, BN>HC
HADSd 9.18 4.79 11.32 4.43 3.37 3.14 41.38 0.00 AN>HC, BN>HC
EDE-Qg 3.23 1.60 3.97 1.26 1.07 0.89 59.89 0.00 AN>HC, BN>HC
EDE-Qr 3.00 1.89 3.17 1.62 0.68 0.81 39.78 0.00 AN>HC, BN>HC
EDE-Qe 3.39 1.70 3.72 1.63 0.47 0.64 75.27 0.00 AN>HC, BN>HC
EDE-Qw 3.74 1.32 4.32 1.45 1.44 1.29 44.73 0.00 AN>HC, BN>HC
EDE-Qs 3.96 1.23 4.56 1.23 1.70 1.25 50.96 0.00 AN>HC, BN>HC
BITEss 8.75 6.32 11.57 5.56 1.37 1.18 67.76 0.00 AN>HC, BN>HC
BITEsas 17.63 10.14 22.61 4.38 5.33 4.46 104.27 0.00 AN>HC, BN>HC
EDI-2 117.06 43.93 139.83 37.19 60.64 29.77 52.29 0.00 AN>HC, BN>HC
MOCI 10.47 5.93 13.55 6.21 7.17 3.34 15.83 0.00 BN>HC
Comobidities; n=
 Dysthymia 3
 Panic disorder 1
 Somatoform 1
 Anxiety disorder 1
 Alcohol dependence 1
Medication; n=
 SSRIs 10

BMI: body mass index; TAS-20: Toronto Alexithymia Scale; EDE-Qg: Eating Disorder Examination Questionnaire (global score); EDE-Qr: restricting; EDE-Qe: eating concern; EDE-Qw: weight concern; EDE-Qs: shape concern; HADSa: Hospital Anxiety and Depression Scale (anxiety); HADSd: Hospital Anxiety and Depression Scale (depression); BITEsas: Bulimia Investigatory Test, Edinburgh: (symptom scale); BITEss: Bulimia Investigatory Test, Edinburgh (severity scale); MOCI: Maudsley Obsessive-Compulsive Inventory; EDI-2: Eating Disorders Inventory 2; SSRIs: selective serotonin reuptake inhibitors.

In bold: p-value <0.05, n.s.: not significant.